Home Life Sciences The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
Article Open Access

The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury

  • Wei Wei , Yibo Zhao , Yan Zhang , Songtao Shou EMAIL logo and Heng Jin EMAIL logo
Published/Copyright: August 31, 2023

Abstract

Sepsis is a syndrome caused by an imbalance in the inflammatory response of the body caused by an infection that leads to organ dysfunction, with the kidney being one of the most commonly affected organs. Sepsis-related acute kidney injury (SAKI) is strongly linked to increased mortality and poor clinical outcomes. Early diagnosis and treatment can significantly reduce patient mortality. On the other hand, the pathogenesis of SAKI is not fully understood, and early diagnosis of SAKI is a clinical challenge. Therefore, the current review describes biomarkers of acute kidney injury in sepsis and discusses the various pathogenic mechanisms involved in the progression of acute kidney injury in sepsis to develop new clinical treatment avenues.

1 Introduction

Sepsis is a serious disease caused by an unbalanced immune response to infections, which results in organ dysfunction. Sepsis can cause multiple organ dysfunction, including kidney dysfunction, leading to sepsis-related acute kidney injury (SAKI) [1]. Although antibiotics and organ function support have improved clinical outcomes, the mortality rate in patients with sepsis remains high [2]. Sepsis accounts for more than 50% of the causes of AKI, thus making it one of the most important causes [3]. This is further borne out by the results of the study of about 200,000 sepsis patients in the United States. The incidence of SAKI was 22%, with a case fatality rate of 38.2% [4]. SAKI has a complex and unique pathogenesis [5,6], and to date, it has been difficult to determine the exact onset time of SAKI in affected patients [7]. The occurrence of S-AKI is linked to negative outcomes. The prognosis of SAKI can be improved with early detection [8]. Therefore, the potential value of markers such as NAGL, kidney injury molecule 1 (KIM-1), insulin-like growth factor binding protein 7 (IGFBP7), and tissue inhibitor of metalloproteinase-2 (TIMP-2), among others, in the early diagnosis of SAKI is constantly being discovered [9,10]. Furthermore, compared to AKI caused by other causes, patients with S-AKI had a higher urinary microscopic score. Urine microscopy is only used to diagnose SAKI [11]. In this review, we identified biomarkers that may help in the early and rapid delineation of patients with SAKI and thus contribute to improved outcomes. We also further explore the complex pathogenesis of SAKI and how it affects disease progression.

2 Biomarkers for the early diagnosis of SAKI

Early detection of SAKI is critical for timely treatment and preventing further kidney damage. Serum creatinine and urea nitrogen measurements are still commonly used clinical indicators to diagnose AKI and to assess the severity and staging of AKI due to their convenience and low cost. On the other hand, serum creatinine and urea nitrogen levels are influenced by factors such as the patient’s age, nutritional metabolism level, and drug clearance rate. Only when the degree of renal injury reaches about 50% or even later in the course of renal injury, the serum creatinine level begins to increase, delaying diagnosis and early intervention [12,13,14]. Currently, many studies on the early diagnostic markers of different injury sites of SAKI (Figure 1) have been reported, and they have shown good sensitivity and specificity, which have early diagnostic value for SAKI (Table 1).

Figure 1 
               Biomarkers of SAKI at different sites. When the kidneys are injured, common biomarkers increase to varying degrees in different parts of the kidney.
Figure 1

Biomarkers of SAKI at different sites. When the kidneys are injured, common biomarkers increase to varying degrees in different parts of the kidney.

Table 1

Partial list of biomarkers for early detection of acute kidney injury in sepsis

Biomarker Source of sample Specificity Sensitivity AUC Reference
NGAL Urine Urine; 0.84 Urine; 0.87 Urine; 0.92 [15]
Serum Plasma; 0.79 Plasma;0.83 Plasma; 0.87
Plasma Plasma; 0.74 Urine; 0.80 Urine; 0.84
KIM-1 Urine 0.74 0.84 0.62 [20]
CysC Serum 0.84 0.82 0.96 [23]
IL-18 Urine NR NR 0.719 [27]
L-FABP Urine 0.74 0.78 0.82 [29]
IGFBP7*TIMP-2 Urine 0.909 0.67 0.89 [32]

Notes: NR, not reported.

Abbreviations: AUC, area under curve; NGAL, neutrophil-associated lipid transporter protein; KIM-1, kidney injury molecule 1; CysC, cystatin C; IL-18, interleukin-18; L-FABP, liver-type fatty acid binding protein; IGFBP7*TIMP-2, insulin-like growth factor binding protein 7*tissue inhibitor of metalloproteinase-2.

2.1 Neutrophil-associated lipid transporter protein (NGAL)

In 1993, Kjeldsen discovered NGAL in cultured activated neutrophils and isolated it from peroxidase particles in neutrophils [15]. NGAL, also known as lipocalin 2 or 24p3, is a secreted protein with a relative molecular mass of 25,000. It widely exists in human tissues and organs including the uterus, liver, stomach, colon, breast, lungs, and kidneys, but it is rarely expressed under normal physiological conditions. When an organ suffers from inflammation, damage, or hemodynamic disorder, the expression of NGAL increases, particularly in the kidney [16]. In recent years, some large-scale basic and clinical studies [17,18] have confirmed that NGAL in urine, serum, and plasma has high sensitivity and specificity in the early diagnosis of SAKI. The sensitivity values of NGAL in urine, serum, and plasma were 0.87, 0.83, and 0.80; the specificity values were 0.84, 0.79, and 0.74; and the area under curves (AUC) were 0.9;2, 0.87, and 0.84. Urinary NGAL has a relatively high diagnostic value compared to serum and plasma NGAL. Therefore, NGAL is now recognized as a useful new marker for diagnosing SAKI.

2.2 KIM-1

KIM-1 is a transmembrane glycoprotein found on the epithelial cells of the proximal tubules of the kidney. KIM-1 expression is low in normal liver, kidney, spleen, and other organs but it increases significantly in renal proximal convoluted tubular epithelial cells (TECs) after kidney injury [19]. KIM-1 increased significantly faster than serum creatinine and urea nitrogen [20]. Tu et al. [21] found that after 24 h of admission to the ICU, the SCr level of SAKI patients began to increase. Urinary KIM-1, on the other hand, began to increase as early as 6 h later, peaked at 24 h, and remained increased for 48 h after admission to the ICU. Geng et al. [22] found that the sensitivity of urinary KIM-1 to diagnose SAKI was 0.74, the specificity was 0.84, and the AUC was 0.62. In summary, it is a better biomarker than serum SCr.

2.3 Cystatin C (CysC)

CysC is a protein with a molecular weight of 13 kDa. It is a cysteine protease inhibitor from the member’s superfamily of cysteine protease inhibitors. It is capable of being synthesized in all nucleated cells and is unaffected by objective factors such as age, gender, dietary structure, or muscle quality [23]. The amount of SCr and urea nitrogen in the body varies with muscle mass and diet [24]. In many studies for early diagnosis of SAKI, CysC was significantly better than SCr. Among them, Nejat et al. [25] compared the detection of functional changes in plasma CysC and plasma SCr in critically ill patients and discovered that the relative increase in plasma CysC occurred earlier than plasma SCr. Furthermore, Zhang et al. [26] demonstrated that the sensitivity and specificity of serum CysC in the early prediction of AKI were 0.84 and 0.82, respectively, with an AUC as high as 0.96. CysC levels in the blood are an effective and earlier predictor of decreased renal function. A recent clinical study by Al-Amodi et al. [27] found that TNF-α (−376 G/A) and cystatin could diagnose S-AKI and predict mortality in critically ill patients. The risk of S-AKI was significantly associated with sCysC, and the combination of sCysC and TNF-α (−376 G/A) outperformed sCysC alone in the diagnosis of S-AKI (AUC = 0.610, 0.838, respectively).

2.4 Interleukin-18 (IL-18)

IL-18 is a pro-inflammatory factor that belongs to the IL-1 cytokine superfamily. Activated monocytes, macrophages, dendritic cells, and NK cells are the most common sources of it [28]. Simultaneously, IL-18 is an inducer of IFN-γ. Increased levels of IL-18 in the body can cause the production of IFN-γ, TNF-α, and other cytokines, as well as the activation of immune-related cells, which can result in a variety of responses against bacteria, viruses, and fungi [29]. Several studies have found that an increase in IL-18 levels in urine can be detected in SAKI patients in 4–6 h, whereas changes in SCr usually take 2–3 days. In comparison to SCr, IL-18 promotes early prediction of the occurrence of SAKI [30]. Zhu and Shi [31] discovered that the IL-18 level of SAKI patients in ICU increased significantly at least 6 h earlier than SCr and that after 6 h, the area under the curve for IL-18 to diagnose SAKI was 0.719, which was better than 0.677 for SCr.

2.5 Liver-type fatty acid binding protein(L-FABP)

L-FABP is a 14 kDa small molecule protein produced primarily in the liver, expressed in various organs, and reabsorbed in the proximal tubules via glomerular filtration [32]. L-FABP is a member of a protein family that transports fatty acids and other lipophilic substances. It regulates lipid metabolism by combining with free fatty acids and transferring between the outer and inner cell membranes. In AKI caused by various causes of renal tubule ischemia and hypoxic stress, the excretion of L-FABP in urine is significantly increased [33]. A recent meta-analysis of 25 studies found that urine L-FABP had a sensitivity of 0.74 and a specificity of 0.78 in predicting AKI [34]. So, it is considered a valuable early biomarker of AKI.

2.6 IGFBP7 and TIMP-2

In 2013, IGFBP7 and TIMP-2 were identified as AKI biomarkers by Kashani et al. [35]. TIMP-2, a member of the tissue inhibitor of the metalloproteinases family and an endogenous inhibitor of metalloproteinase activity, has a molecular weight of about 24 kDa; IGFBP7 is a 29 kDa secretory protein; and they are all expressed and secreted by renal tubular cells [36]. TIMP-2 and IGFBP7 are produced and released by renal tubular cells in the early stages of injury caused by various injuries (such as sepsis, ischemia, and oxidative stress). TIMP-2 promotes the expression of p27, whereas IGFBP7 promotes the expression of p53 and p21. These proteins then inhibit the cyclin-dependent protein kinase complex (CyclD-CDK4 and CyclE-CDK2), causing transient G1 cell cycle arrest [35]. Nusshag et al. [37] recently discovered that [TIMP-2] × [IGFBP7] predicted the AUC of SAKI was 0.89, sensitivity was 0.909, and specificity was 0.67. Godi et al. [38] also demonstrated that combining [TIMP-2] × [IGFBP7] and PCT results may be an effective tool for identifying patients with SAKI and high-risk ICU short-term adverse outcomes.

3 Pathogenic mechanisms

Obviously, SAKI is usually caused by a complex mechanism rather than a single factor. Different pathogenesis causes kidney injury in different parts of the body. As previously stated, different markers are elevated in various parts of the kidney injury. It is unclear whether using the same markers to diagnose the injury of all kidney regions of SAKI improves the accuracy of early diagnosis and location of the injury [39]. Therefore, we will expand on the currently known pathogenesis of SAKI. The combination of different pathogenesis of SAKI and biomarker diagnosis at different sites of SAKI will aid in detecting clinical problems of SAKI early on and taking intervention measures to improve the prognosis of SAKI patients. Combining the various pathogenesis of SAKI and the diagnosis of biomarkers in different parts of SAKI will aid in identifying clinical problems of SAKI early on and taking intervention measures to improve the prognosis of SAKI patients.

3.1 Imbalance of inflammatory response

SAKI is a systemic inflammatory response syndrome caused by infections resulting in kidney dysfunction (Figure 1). Anti-inflammatory and pro-inflammatory factors disrupt the dynamic balance, resulting in a cascading inflammatory response storm, which has long been recognized as a key pathogenesis of the SAKI mechanism [6]. During SAKI, inflammatory mediators bind to membrane-bound pattern recognition receptors expressed by TECs, triggering a cascade of downstream signals that leads to the synthesis and release of pro-inflammatory factors. This resulted in renal tubule in necrosis and inflammatory cell infiltration in septic mice [5]. So far, a large number of studies have summarized the important role of inflammatory factors in AKI [40,41]. TNF, one of many inflammatory mediators and cytokines, can positively induce and promote the production of other inflammatory factors, resulting in the release of a large number of cytokines and producing a “waterfall effect” and is thus regarded as the key initiating factor for SAKI [42]. In clinical studies, Quinto et al. [43] found that severe SAKI patients with TNF removed by hemodialysis have lower mortality, which may be due to a weakening of the inflammatory response.

3.2 Cell death

Apoptosis refers to programmed cell death. Normal apoptosis is a response to the cell microenvironment that is essential for maintaining intracellular homeostasis [44]. A large number of renal tubular cells undergo inflammation, oxidative stress, and renal I/R injury in the early stages of SAKI’s kidney tissue, resulting in excessive renal tubular cell apoptosis. Multiple pathways, including internal (mitochondrial permeability transition pores, Bcl-2 family, cytochrome c, caspase-9) and external pathways, act together to cause apoptosis (FAS, FADD, caspase-8). On the one hand, in response to inflammation, cells undergo DNA damage, oxidative stress, and cellular stress, which can trigger endogenous cell apoptosis. In addition, cytochrome c released into the cytoplasm can interact with apoptosis-related factor 1 in the presence of dATP (Apaf-1) to form multimers, prompting caspase-9 to combine with it to form apoptotic bodies, and caspase-9 could activate caspase-3 after being activated. The binding of Fas and FasL, which are trimerized via the exogenous pathway, attracts the protein FADD with the same death domain in the cytoplasm to further synthesize with the inactive pro-caspase 8 (caspase-8) zymogen. The tropism cross-links and the caspase-8 molecule is then converted from a single-chain zymogen into an active double-chain protein, resulting in a cascade reaction, namely caspases [45], and the two pathways eventually act on caspase-3 to initiate the final apoptotic cascade. Caspase-3 is thus the “central link” in the process of cell apoptosis [46] (Figure 2). Yang et al. [47] confirmed in vivo that caspase-3 deficiency reduces microvascular endothelial apoptosis, renal tubular ischemia, and renal interstitial fibrosis in AKI mice. Furthermore, Ying et al. [48] discovered that drugs that inhibit caspase-3 expression could significantly protect SAKI mice and improve survival rates.

Figure 2 
                  Inflammation disorder and apoptosis caused by severe infection. After human infection, pathogen-related molecular pattern PAMPs and disease-related molecular pattern DAMPs are recognized by toll-like receptors, activate NF-κB and MAPK inflammatory pathways, and induce immune cells (such as NK cells and macrophages) to secrete anti-inflammatory pro-inflammatory cytokines, which in turn trigger cell death.
Figure 2

Inflammation disorder and apoptosis caused by severe infection. After human infection, pathogen-related molecular pattern PAMPs and disease-related molecular pattern DAMPs are recognized by toll-like receptors, activate NF-κB and MAPK inflammatory pathways, and induce immune cells (such as NK cells and macrophages) to secrete anti-inflammatory pro-inflammatory cytokines, which in turn trigger cell death.

3.3 Cellular senescence

Cellular senescence is a type of cell cycle arrest brought about DNA damage, inflammatory responses, oxidative stress, and epigenetic changes. DNA double-strand breaks, changes in cyclins, increased expression of cellular senescence-related proteins, and β-galactosidase are all hallmarks of cellular senescence. Simultaneously, senescent cells secrete senescence-associated secretory phenotype, which contains a variety of inflammatory factors such as interleukin-6 (IL-6) and transforming growth factor (TGF-β), etc. (Figure 3). Several studies in recent years have confirmed that cellular senescence plays a role in a variety of kidney diseases [49]. Jin et al. [50] confirmed that the TECs in mice with early AKI have undergone cellular senescence using AKI models induced by nephrotoxicity and ischemia-reperfusion injury. Furthermore, specifically knocking out the myeloid differentiation factor (Myd88) gene of TECs can reduce not only pro-inflammatory factors, interstitial infiltration, and fibrosis but also senescent cell aggregation and renal tubular damage, demonstrating that the TLR/Myd88/NF-κB pathway is an important pathway in mediating cellular senescence in TECs. Chen et al. [51] discovered that in the early stages of SAKI, Lipoxin A4 exerts anti-aging and anti-inflammatory effects via the PPAR-γ/NF-κB pathway, helping to improve renal function.

Figure 3 
                  Typical features of senescence in renal TECs. Following SAKI, normal TECs undergo cellular senescence under conditions of DNA damage, inflammatory responses, oxidative stress, and epigenetic alterations.
Figure 3

Typical features of senescence in renal TECs. Following SAKI, normal TECs undergo cellular senescence under conditions of DNA damage, inflammatory responses, oxidative stress, and epigenetic alterations.

3.4 Mitochondrial dysfunction

The primary function of mitochondria is to generate energy. Because the kidney is a high-metabolic organ with a high energy demand, it is abundant in mitochondria [52]. When there is mitochondrial dysfunction, on the one hand, it will cause a decrease in ATP production and an increase in reactive oxygen species (ROS), resulting in a significant deterioration of renal function [53]. In contrast, ROS overload will cause a disruption mitochondrial electron transport chain and a change in membrane permeability. The release of cytochrome c promotes the occurrence of apoptosis and inflammatory response. Conversely, mitochondrial physiological autophagy and mitochondrial regeneration are critical in the recovery of renal function [54]. PGC-1α (PPARγ co-activator-1α) is a key regulator of mitochondrial regeneration [55]. When SAKI occurs, the kidney’s decreased expression of PGC-1α has a weakened protective effect on mitochondrial function, and the level of PGC-1α is directly related to the degree of renal injury [56]. Therefore, mitochondrial dysfunction is an important pathogenesis of SAKI, and mitochondrial function recovery is linked to renal function recovery.

3.5 Coagulation dysfunction

SAKI coagulation dysfunction is primarily caused by an imbalance between coagulation and anticoagulation in sepsis patients, endothelial injury and inflammatory response, fibrin mass production, and disruption of the fibrinolytic system [57]. SAKI frequently sets off a chain reaction of inflammatory storms, and the overexpression of inflammatory factors is related to coagulation dysfunction. Thrombin can stimulate inflammatory cytokines and the complement system, as well as platelet aggregation and white blood cell activation, resulting in diffuse microvascular injury. Antithrombin (AT) regulates thrombin but, in severe sepsis, the half-life of AT is shortened due to increased elastase destruction by activated neutrophils [58]. Furthermore, activated protein C is an endogenous anticoagulant with anti-inflammatory properties that is downregulated in sepsis [59]. Increased AT destruction due to thrombin dysregulation and decreased production of activated protein C will result in uncontrolled blood clotting. These effects may cause microvascular thrombosis and renal microcirculation injury, thereby aggravating the severity of SAKI. An ICU clinical study [60] discovered that, when compared to non-AKI patients, SAKI patients had significantly higher levels of APTT, PT, and D-dimers, and that APTT prolongation was independently related to patient mortality. APTT can be used to predict 30-day mortality independently.

3.6 Ischemia reperfusion injury

SAKI complicated by vascular endothelial injury, blood hypercoagulability, and overexpression of inflammatory factors can result in severe renal artery blood supply, insufficiency, resulting in ischemia and hypoxia of renal tissue. After a period of time, as the disease recovers, the vascular endothelial injury is repaired and hypercoagulable. After the blood supply to the kidney tissue is restored, thrombolysis, inflammation, and infection can be effectively controlled, and reperfusion injury can occur [61]. When the renal parenchymal cells are insufficiently perfused, the cellular mechanisms that maintain cell integrity are disrupted, leading to the initiation of the apoptosis pathway, and histological changes such as the disappearance of the brush border of the proximal tubules, the expansion of the distal tubules, and the formation of casts will further cause kidney obstruction. Intracellular calcium processing, xanthine signal transduction, and the formation of reactive oxidative substances are all involved in the process [62]. Furthermore, it is easy to produce a large number of oxygen free radicals and hydroxyl free radicals, during the process of restoring blood supply to the kidneys, which degrade polyunsaturated fatty acids in biofilms to cause lipid peroxidation and damage the structure and function of cells and mitochondrial membranes [63].

3.7 Autophagy

Autophagy is an intracellular decomposition process [64]. The body degrades organelles and proteins and forms autophagosomes when hunger or other pressures are stimulated to achieve cell homeostasis and organelle renewal [65]. Micro autophagy, macro autophagy, and molecular chaperone-mediated autophagy are the three main types of autophagy. The autophagy regulation mechanism is complex, with mTOR-dependent and mTOR-independent signaling pathways (AMPK, PI3K, Ras-MAPK, p53, PTEN) [66,67]. Under acute or chronic injury, moderate autophagy can play a renal protective role by regulating resident renal TECs [68]. On the one hand, renal injury causes an inflammatory cytokine storm, whereas autophagy has the ability to inhibit SAKI by targeting inflammatory bodies to regulate infection and prevent kidney disease [69]. Autophagy, on the other hand, can activate type I IFN reactions and promote IL-1B secretion [70]. Therefore, the pro-inflammatory and anti-inflammatory balance of autophagy can help prevent kidney disease caused by an overactive inflammatory response. An excessive inflammatory response is ultimately attributed to renal tubular epithelial injury and apoptosis, and autophagy plays an important role in renal tubular epithelial repair. Deng et al. found that SIRT1 alleviates SAKI via Beclin1 deacetylation-mediated autophagy activation, reduces creatinine urea nitrogen levels to some extent, and reduces renal tubular epithelial damage [71]. Similarly, Sun et al. confirmed in animal and cell experiments that p53 deacetylation promoted autophagy and alleviated SAKI [72].

4 Conclusion

Sepsis is a serious disease with a high morbidity and mortality rate. Multiple organ failure, particularly AKI frequently complicates sepsis. Patients with SAKI have a longer hospital stay and a higher risk of death in the hospital, which increases with the severity of AKI [73,74]. In clinical practice, the prognosis of SAKI patients is not encouraging, and the main treatments are dialysis and symptomatic and supportive care [75]. Individuals and countries bear a massive medical and economic burden as a result. Fortunately, the majority of the SAKI biomarkers discussed may be useful in early detection. Urine NGAL, plasma NGAL, CysC, IGFBP7, TIMP-2, and KIM-1 were the most promising. In addition to creatinine and urea nitrogen, urine NGAL, plasma NGAL, and KIM-1 are now frequently used as common indicators to assess kidney injury [39]. Furthermore, an increase in these markers may indicate the need for early RRT [76], with reference to a complex assessment of clinical parameters to reduce kidney injury and improve SAKI outcomes. Similarly, investigating pathogenesis may yield new ideas for treating SAKI. Recent research [77] has revealed that Klotho, as a protein expressed by renal cells, has anti-aging antioxidant properties. Klotho deficiency may worsen the severity of organ dysfunction in SAKI. Perhaps, this indicates that cellular senescence is one of the underlying pathogenesis of SAKI, pointing to a new treatment approach. Although progress in S-AKI pathogenesis has largely reached a new level in comparison to the past due to the promotion of in vitro and in vivo experiments, understanding of S-AKI pathogenesis still faces certain limitations [78]. Because of the critical condition of S-AKI patients, the risk of renal tissue biopsy far outweighs the benefit of pathological diagnosis, and data on the dynamic changes of S-AKI pathophysiology are lacking. Biopsy studies on patients who died from SAKI may provide some answers but the relevant data are limited due to medical ethics. To summarize, the ongoing advancement of diagnostic biomarkers and the pathogenesis of SAKI is beneficial for early targeted treatment and improvement of the kidney prognosis of SAKI. Following that, we may need to focus on the clinical application of biomarkers to better understand the role of multiple mechanisms inducing SAKI, as well as their relationship, and whether they can be converted into new therapeutic interventions.

  1. Funding information: This manuscript was supported by grants from the National Natural Science Foundation of China (Grant Number: 82072222) (H.J.), the Science and Technology Fund of Tianjin Municipal Education Commission (Grant Number: 2021KJ216) (Y.Z.), and the Science and Technology Fund of Tianjin Municipal Health Bureau (Grant Number: ZC20180) (H.J.).

  2. Author contributions: Conceptualization, Yan Zhang; design, Heng Jin and Songtao Shou; writing – original draft preparation, Wei Wei; writing – review and editing, Heng Jin and Songtao Shou. All authors have read and agreed to the published version of the manuscript.

  3. Conflict of interest: Authors state no conflict of interest.

  4. Data availability statement: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364:k4891.10.1136/bmj.k4891Search in Google Scholar PubMed PubMed Central

[2] Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75–87.10.1016/S0140-6736(18)30696-2Search in Google Scholar PubMed

[3] Hoste EAJ, Kellum JA, Selby NM, Zarbock A, Palevsky PM, Bagshaw SM, et al. Global epidemiology and outcomes of acute kidney injury. Nat Rev Nephrol. 2018;14(10):607–25.10.1038/s41581-018-0052-0Search in Google Scholar PubMed

[4] Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med. 2017;43(6):816–28.10.1007/s00134-017-4755-7Search in Google Scholar PubMed

[5] Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083–99.10.1016/j.kint.2019.05.026Search in Google Scholar PubMed PubMed Central

[6] Manrique-Caballero CL, Del Rio-Pertuz G, Gomez H. Sepsis-associated acute kidney injury. Crit Care Clin. 2021;37(2):279–301.10.1016/j.ccc.2020.11.010Search in Google Scholar PubMed PubMed Central

[7] Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193(3):281–7.10.1164/rccm.201505-0995OCSearch in Google Scholar PubMed PubMed Central

[8] Pozzato M, Livigni S, Roccatello D. Extracorporeal therapy in sepsis. G Ital Nefrol. 2019;36(2).Search in Google Scholar

[9] Ragán D, Horváth-Szalai Z, Szirmay B, Mühl D. Novel damage biomarkers of sepsis-related acute kidney injury. Ejifcc. 2022;33(1):11–22.Search in Google Scholar

[10] Li S, Ren S, Long L, Zhao H, Shen L. Evaluation of the efficiency of TIMP-2 as a biomarker for acute kidney injury in sepsis. Bull Exp Biol Med. 2023;174(6):790–6.10.1007/s10517-023-05791-5Search in Google Scholar PubMed

[11] Bagshaw SM, Haase M, Haase-Fielitz A, Bennett M, Devarajan P, Bellomo R. A prospective evaluation of urine microscopy in septic and non-septic acute kidney injury. Nephrol Dial Transpl. 2012;27(2):582–8.10.1093/ndt/gfr331Search in Google Scholar PubMed

[12] Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med. 2004;30(1):33–7.10.1007/s00134-003-2078-3Search in Google Scholar PubMed

[13] Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec’h C, et al. Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies). Ann Intensive Care. 2016;6(1):48.10.1186/s13613-016-0145-5Search in Google Scholar PubMed PubMed Central

[14] Zhang Z. Biomarkers, diagnosis and management of sepsis-induced acute kidney injury: A narrative review. Heart Lung Vessel. 2015;7(1):64–73.Search in Google Scholar

[15] Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268(14):10425–32.10.1016/S0021-9258(18)82217-7Search in Google Scholar

[16] Kulvichit W, Kellum JA, Srisawat N. Biomarkers in acute kidney injury. Crit Care Clin. 2021;37(2):385–98.10.1016/j.ccc.2020.11.012Search in Google Scholar PubMed

[17] Zhou H, Cui J, Lu Y, Sun J, Liu J. Meta-analysis of the diagnostic value of serum, plasma and urine neutrophil gelatinase-associated lipocalin for the detection of acute kidney injury in patients with sepsis. Exp Ther Med. 2021;21(4):386.10.3892/etm.2021.9817Search in Google Scholar PubMed PubMed Central

[18] Marcello M, Virzì GM, Muciño-Bermejo MJ, Milan Manani S, Giavarina D, Salvador L, et al. Subclinical AKI and clinical outcomes in elderly patients undergoing cardiac surgery: Diagnostic utility of NGAL versus standard creatinine increase criteria. Cardiorenal Med. 2022;12(3):94–105.10.1159/000525221Search in Google Scholar PubMed

[19] Moresco RN, Bochi GV, Stein CS, De Carvalho JAM, Cembranel BM, Bollick YS. Urinary kidney injury molecule-1 in renal disease. Clin Chim Acta. 2018;487:15–21.10.1016/j.cca.2018.09.011Search in Google Scholar PubMed

[20] Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: The pathway from discovery to clinical adoption. Clin Chem Lab Med. 2017;55(8):1074–89.10.1515/cclm-2016-0973Search in Google Scholar PubMed

[21] Tu Y, Wang H, Sun R, Ni Y, Ma L, Xv F, et al. Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail. 2014;36(10):1559–63.10.3109/0886022X.2014.949764Search in Google Scholar PubMed

[22] Geng J, Qiu Y, Qin Z, Su B. The value of kidney injury molecule 1 in predicting acute kidney injury in adult patients: A systematic review and Bayesian meta-analysis. J Transl Med. 2021;19(1):105.10.1186/s12967-021-02776-8Search in Google Scholar PubMed PubMed Central

[23] Macisaac RJ, Premaratne E, Jerums G. Estimating glomerular filtration rate in diabetes using serum cystatin C. Clin Biochem Rev. 2011;32(2):61–7.Search in Google Scholar

[24] Bilgili B, Haliloğlu M, Cinel İ. Sepsis and acute kidney injury. Turk J Anaesthesiol Reanim. 2014;42(6):294–301.10.5152/TJAR.2014.83436Search in Google Scholar PubMed PubMed Central

[25] Nejat M, Pickering JW, Walker RJ, Endre ZH. Rapid detection of acute kidney injury by plasma cystatin C in the intensive care unit. Nephrol Dial Transpl. 2010;25(10):3283–9.10.1093/ndt/gfq176Search in Google Scholar PubMed

[26] Zhang Z, Lu B, Sheng X, Jin N. Cystatin C in prediction of acute kidney injury: A systemic review and meta-analysis. Am J Kidney Dis. 2011;58(3):356–65.10.1053/j.ajkd.2011.02.389Search in Google Scholar PubMed

[27] Al-Amodi HS, Abdelsattar S, Kasemy ZA, Bedair HM, Elbarbary HS, Kamel HFM. Potential value of TNF-α (-376 G/A) polymorphism and cystatin C (CysC) in the diagnosis of sepsis associated acute kidney injury (S-AK I) and prediction of mortality in critically Ill patients. Front Mol Biosci. 2021;8:751299.10.3389/fmolb.2021.751299Search in Google Scholar PubMed PubMed Central

[28] Yasuda K, Nakanishi K, Tsutsui H. Interleukin-18 in health and disease. Int J Mol Sci. 2019;20(3):649.10.3390/ijms20030649Search in Google Scholar PubMed PubMed Central

[29] Schrezenmeier EV, Barasch J, Budde K, Westhoff T, Schmidt-Ott KM. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta Physiol (Oxf). 2017;219(3):554–72.10.1111/apha.12764Search in Google Scholar PubMed PubMed Central

[30] Andreucci M, Faga T, Pisani A, Perticone M, Michael A. The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice. Eur J Intern Med. 2017;39:1–8.10.1016/j.ejim.2016.12.001Search in Google Scholar PubMed

[31] Zhu L, Shi D. [Early diagnostic value of neutrophil gelatinase-associated lipocalin and interleukin-18 in patients with sepsis-induced acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016;28(8):718–22.Search in Google Scholar

[32] Manabe K, Kamihata H, Motohiro M, Senoo T, Yoshida S, Iwasaka T. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury. Eur J Clin Invest. 2012;42(5):557–63.10.1111/j.1365-2362.2011.02620.xSearch in Google Scholar PubMed

[33] Ohata K, Sugaya T, Nguyen HN, Hatanaka Y, Uno K, Tohma M, et al. Urinary liver-type fatty acid binding protein is increased in the early stages of the disease with a risk of acute kidney injury induced by histone. Nephrology (Carlton). 2023;28(6):345–55.10.1111/nep.14162Search in Google Scholar PubMed

[34] Chiang TH, Yo CH, Lee GH, Mathew A, Sugaya T, Li WY, et al. Accuracy of liver-type fatty acid-binding protein in predicting acute kidney injury: A meta-analysis. J Appl Lab Med. 2021;7(2):421–36.10.1093/jalm/jfab092Search in Google Scholar PubMed

[35] Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25.10.1186/cc12503Search in Google Scholar PubMed PubMed Central

[36] Emlet DR, Pastor-Soler N, Marciszyn A, Wen X, Gomez H, Humphries WH, et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: differential expression and secretion in human kidney tubule cells. Am J Physiol Ren Physiol. 2017;312(2):F284–96.10.1152/ajprenal.00271.2016Search in Google Scholar PubMed PubMed Central

[37] Nusshag C, Rupp C, Schmitt F, Krautkrämer E, Speer C, Kälble F, et al. Cell cycle biomarkers and soluble urokinase-Type plasminogen activator receptor for the prediction of sepsis-induced acute kidney injury requiring renal replacement therapy: A prospective, exploratory study. Crit Care Med. 2019;47(12):e999–1007.10.1097/CCM.0000000000004042Search in Google Scholar PubMed PubMed Central

[38] Godi I, De Rosa S, Martino F, Bazzano S, Martin M, Boni E, et al. Urinary [TIMP-2]  ×  [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients. Ann Intensive Care. 2020;10(1):46.10.1186/s13613-020-00665-9Search in Google Scholar PubMed PubMed Central

[39] Wang K, Xie S, Xiao K, Yan P, He W, Xie L. Biomarkers of sepsis-induced acute kidney injury. Biomed Res Int. 2018;2018:6937947.10.1155/2018/6937947Search in Google Scholar PubMed PubMed Central

[40] Wang Y, Zhang Y, Shou S, Jin H. The role of IL-17 in acute kidney injury. Int Immunopharmacol. 2023;119:110307.10.1016/j.intimp.2023.110307Search in Google Scholar PubMed

[41] Wei W, Zhao Y, Zhang Y, Jin H, Shou S. The role of IL-10 in kidney disease. Int Immunopharmacol. 2022;108:108917.10.1016/j.intimp.2022.108917Search in Google Scholar PubMed

[42] Sethi JK, Hotamisligil GS. Metabolic Messengers: Tumour necrosis factor. Nat Metab. 2021;3(10):1302–12.10.1038/s42255-021-00470-zSearch in Google Scholar PubMed

[43] Quinto BM, Iizuka IJ, Monte JC, Santos BF, Pereira V, Durão MS, et al. TNF-α depuration is a predictor of mortality in critically ill patients under continuous veno-venous hemodiafiltration treatment. Cytokine. 2015;71(2):255–60.10.1016/j.cyto.2014.10.024Search in Google Scholar PubMed

[44] Priante G, Gianesello L, Ceol M, Del Prete D, Anglani F. Cell death in the kidney. Int J Mol Sci. 2019;20(14).10.3390/ijms20143598Search in Google Scholar PubMed PubMed Central

[45] Kashyap D, Garg VK, Goel N. Intrinsic and extrinsic pathways of apoptosis: Role in cancer development and prognosis. Adv Protein Chem Struct Biol. 2021;125:73–120.10.1016/bs.apcsb.2021.01.003Search in Google Scholar PubMed

[46] Han SJ, Lee HT. Mechanisms and therapeutic targets of ischemic acute kidney injury. Kidney Res Clin Pract. 2019;38(4):427–40.10.23876/j.krcp.19.062Search in Google Scholar PubMed PubMed Central

[47] Yang B, Lan S, Dieudé M, Sabo-Vatasescu JP, Karakeussian-Rimbaud A, Turgeon J, et al. Caspase-3 is a pivotal regulator of microvascular rarefaction and renal fibrosis after ischemia-reperfusion injury. J Am Soc Nephrol. 2018;29(7):1900–16.10.1681/ASN.2017050581Search in Google Scholar PubMed PubMed Central

[48] Ying J, Wu J, Zhang Y, Han Y, Qian X, Yang Q, et al. Ligustrazine suppresses renal NMDAR1 and caspase-3 expressions in a mouse model of sepsis-associated acute kidney injury. Mol Cell Biochem. 2020;464(1-2):73–81.10.1007/s11010-019-03650-4Search in Google Scholar PubMed

[49] Lin X, Jin H, Chai Y, Shou S. Cellular senescence and acute kidney injury. Pediatr Nephrol. 2022;37(12):3009–18.10.1007/s00467-022-05532-2Search in Google Scholar PubMed PubMed Central

[50] Jin H, Zhang Y, Ding Q, Wang SS, Rastogi P, Dai DF, et al. Epithelial innate immunity mediates tubular cell senescence after kidney injury. JCI Insight. 2019;4(2):e125490.10.1172/jci.insight.125490Search in Google Scholar PubMed PubMed Central

[51] Chen C, Qiu R, Yang J, Zhang Q, Sun G, Gao X, et al. Lipoxin A4 restores septic renal function via blocking crosstalk between inflammation and premature senescence. Front Immunol. 2021;12:637753.10.3389/fimmu.2021.637753Search in Google Scholar PubMed PubMed Central

[52] Bhatia D, Capili A, Choi ME. Mitochondrial dysfunction in kidney injury, inflammation, and disease: Potential therapeutic approaches. Kidney Res Clin Pract. 2020;39(3):244–58.10.23876/j.krcp.20.082Search in Google Scholar PubMed PubMed Central

[53] Honda T, Hirakawa Y, Nangaku M. The role of oxidative stress and hypoxia in renal disease. Kidney Res Clin Pract. 2019;38(4):414–26.10.23876/j.krcp.19.063Search in Google Scholar PubMed PubMed Central

[54] Emma F, Montini G, Parikh SM, Salviati L. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol. 2016;12(5):267–80.10.1038/nrneph.2015.214Search in Google Scholar PubMed PubMed Central

[55] Fontecha-Barriuso M, Martin-Sanchez D, Martinez-Moreno JM, Monsalve M, Ramos AM, Sanchez-Niño MD, et al. The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules. 2020;10(2):347.10.3390/biom10020347Search in Google Scholar PubMed PubMed Central

[56] Li SY, Susztak K. The role of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) in kidney disease. Semin Nephrol. 2018;38(2):121–6.10.1016/j.semnephrol.2018.01.003Search in Google Scholar PubMed PubMed Central

[57] Fani F, Regolisti G, Delsante M, Cantaluppi V, Castellano G, Gesualdo L, et al. Recent advances in the pathogenetic mechanisms of sepsis-associated acute kidney injury. J Nephrol. 2018;31(3):351–9.10.1007/s40620-017-0452-4Search in Google Scholar PubMed

[58] Shum HP, Yan WW, Chan TM. Recent knowledge on the pathophysiology of septic acute kidney injury: A narrative review. J Crit Care. 2016;31(1):82–9.10.1016/j.jcrc.2015.09.017Search in Google Scholar PubMed

[59] Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007;35(9):2191–5.10.1097/01.CCM.0000281468.94108.4BSearch in Google Scholar PubMed

[60] Xu Z, Cheng B, Fu S, Liu X, Xie G, Li Z, et al. Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection. Infect Drug Resist. 2019;12:2755–64.10.2147/IDR.S218592Search in Google Scholar PubMed PubMed Central

[61] Wu MY, Yiang GT, Liao WT, Tsai AP, Cheng YL, Cheng PW, et al. Current mechanistic concepts in ischemia and reperfusion injury. Cell Physiol Biochem. 2018;46(4):1650–67.10.1159/000489241Search in Google Scholar PubMed

[62] Prowle JR, Bellomo R. Sepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulation. Semin Nephrol. 2015;35(1):64–74.10.1016/j.semnephrol.2015.01.007Search in Google Scholar PubMed

[63] Aksoy Y, Yapanoglu T, Aksou H, Yildirim AK. The effect of dehydroepiandrosterone on renal ischemia-reperfusion-induced oxidative stress in rabbits. Urol Res. 2004;32(2):93–6.10.1007/s00240-003-0382-6Search in Google Scholar PubMed

[64] Cao W, Li J, Yang K, Cao D. An overview of autophagy: Mechanism, regulation and research progress. Bull Cancer. 2021;108(3):304–22.10.1016/j.bulcan.2020.11.004Search in Google Scholar PubMed

[65] Li W, He P, Huang Y, Li YF, Lu J, Li M, et al. Selective autophagy of intracellular organelles: Recent research advances. Theranostics. 2021;11(1):222–56.10.7150/thno.49860Search in Google Scholar PubMed PubMed Central

[66] Chiou JT, Huang CH, Lee YC, Wang LJ, Shi YJ, Chen YJ, et al. Compound C induces autophagy and apoptosis in parental and hydroquinone-selected malignant leukemia cells through the ROS/p38 MAPK/AMPK/TET2/FOXP3 axis. Cell Biol Toxicol. 2020;36(4):315–31.10.1007/s10565-019-09495-3Search in Google Scholar PubMed

[67] Kim YM, Jung CH, Seo M, Kim EK, Park JM, Bae SS, et al. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol Cell. 2015;57(2):207–18.10.1016/j.molcel.2014.11.013Search in Google Scholar PubMed PubMed Central

[68] Choi ME. Autophagy in kidney disease. Annu Rev Physiol. 2020;82:297–322.10.1146/annurev-physiol-021119-034658Search in Google Scholar PubMed

[69] Kimura T, Isaka Y, Yoshimori T. Autophagy and kidney inflammation. Autophagy. 2017;13(6):997–1003.10.1080/15548627.2017.1309485Search in Google Scholar PubMed PubMed Central

[70] Kimura T, Jia J, Kumar S, Choi SW, Gu Y, Mudd M, et al. Dedicated SNAREs and specialized TRIM cargo receptors mediate secretory autophagy. Embo J. 2017;36(1):42–60.10.15252/embj.201695081Search in Google Scholar PubMed PubMed Central

[71] Deng Z, Sun M, Wu J, Fang H, Cai S, An S, et al. SIRT1 attenuates sepsis-induced acute kidney injury via Beclin1 deacetylation-mediated autophagy activation. Cell Death Dis. 2021;12(2):217.10.1038/s41419-021-03508-ySearch in Google Scholar PubMed PubMed Central

[72] Sun M, Li J, Mao L, Wu J, Deng Z, He M, et al. p53 deacetylation alleviates sepsis-induced acute kidney injury by promoting autophagy. Front Immunol. 2021;12:685523.10.3389/fimmu.2021.685523Search in Google Scholar PubMed PubMed Central

[73] Lopes JA, Jorge S, Resina C, Santos C, Pereira A, Neves J, et al. Acute kidney injury in patients with sepsis: A contemporary analysis. Int J Infect Dis. 2009;13(2):176–81.10.1016/j.ijid.2008.05.1231Search in Google Scholar PubMed

[74] Sood MM, Shafer LA, Ho J, Reslerova M, Martinka G, Keenan S, et al. Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care. 2014;29(5):711–7.10.1016/j.jcrc.2014.04.003Search in Google Scholar PubMed

[75] Matuszkiewicz-Rowińska J, Małyszko J. Acute kidney injury, its definition, and treatment in adults: guidelines and reality. Pol Arch Intern Med. 2020;130(12):1074–80.10.20452/pamw.15373Search in Google Scholar PubMed

[76] Chen WY, Cai LH, Zhang ZH, Tao LL, Wen YC, Li ZB, et al. The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): Study protocol for a multicentre, randomised controlled trial. BMJ Open. 2021;11(2):e040718.10.1136/bmjopen-2020-040718Search in Google Scholar PubMed PubMed Central

[77] Jorge LB, Coelho FO, Sanches TR, Malheiros D, Ezaquiel de Souza L, Dos, Santos F, et al. Klotho deficiency aggravates sepsis-related multiple organ dysfunction. Am J Physiol Ren Physiol. 2019;316(3):F438–48.10.1152/ajprenal.00625.2017Search in Google Scholar PubMed

[78] Ricci Z, Polito A, Polito A, Ronco C. The implications and management of septic acute kidney injury. Nat Rev Nephrol. 2011;7(4):218–25.10.1038/nrneph.2011.15Search in Google Scholar PubMed

Received: 2022-10-12
Revised: 2023-05-19
Accepted: 2023-07-30
Published Online: 2023-08-31

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Biomedical Sciences
  2. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers
  3. Immunosuppressive treatment for idiopathic membranous nephropathy: An updated network meta-analysis
  4. Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy
  5. Effects of phytoestrogens combined with cold stress on sperm parameters and testicular proteomics in rats
  6. A case of pulmonary embolism with bad warfarin anticoagulant effects caused by E. coli infection
  7. Neutrophilia with subclinical Cushing’s disease: A case report and literature review
  8. Isoimperatorin alleviates lipopolysaccharide-induced periodontitis by downregulating ERK1/2 and NF-κB pathways
  9. Immunoregulation of synovial macrophages for the treatment of osteoarthritis
  10. Novel CPLANE1 c.8948dupT (p.P2984Tfs*7) variant in a child patient with Joubert syndrome
  11. Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
  12. Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
  13. High glucose and high lipid induced mitochondrial dysfunction in JEG-3 cells through oxidative stress
  14. Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth
  15. Levocarnitine regulates the growth of angiotensin II-induced myocardial fibrosis cells via TIMP-1
  16. Age-related changes in peripheral T-cell subpopulations in elderly individuals: An observational study
  17. Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
  18. Identification of iron metabolism-related genes as diagnostic signatures in sepsis by blood transcriptomic analysis
  19. Long noncoding RNA ACART knockdown decreases 3T3-L1 preadipocyte proliferation and differentiation
  20. Surgery, adjuvant immunotherapy plus chemotherapy and radiotherapy for primary malignant melanoma of the parotid gland (PGMM): A case report
  21. Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
  22. Soy isoflavone reduces LPS-induced acute lung injury via increasing aquaporin 1 and aquaporin 5 in rats
  23. Refractory hypokalemia with sexual dysplasia and infertility caused by 17α-hydroxylase deficiency and triple X syndrome: A case report
  24. Meta-analysis of cancer risk among end stage renal disease undergoing maintenance dialysis
  25. 6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress
  26. Experimental study on the optimization of ANM33 release in foam cells
  27. Primary retroperitoneal angiosarcoma: A case report
  28. Metabolomic analysis-identified 2-hydroxybutyric acid might be a key metabolite of severe preeclampsia
  29. Malignant pleural effusion diagnosis and therapy
  30. Effect of spaceflight on the phenotype and proteome of Escherichia coli
  31. Comparison of immunotherapy combined with stereotactic radiotherapy and targeted therapy for patients with brain metastases: A systemic review and meta-analysis
  32. Activation of hypermethylated P2RY1 mitigates gastric cancer by promoting apoptosis and inhibiting proliferation
  33. Association between the VEGFR-2 -604T/C polymorphism (rs2071559) and type 2 diabetic retinopathy
  34. The role of IL-31 and IL-34 in the diagnosis and treatment of chronic periodontitis
  35. Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features
  36. mNGS facilitates the accurate diagnosis and antibiotic treatment of suspicious critical CNS infection in real practice: A retrospective study
  37. The apatinib and pemetrexed combination has antitumor and antiangiogenic effects against NSCLC
  38. Radiotherapy for primary thyroid adenoid cystic carcinoma
  39. Design and functional preliminary investigation of recombinant antigen EgG1Y162–EgG1Y162 against Echinococcus granulosus
  40. Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
  41. Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics
  42. Performance comparison of three scaling algorithms in NMR-based metabolomics analysis
  43. PI3K/AKT/mTOR pathway and its related molecules participate in PROK1 silence-induced anti-tumor effects on pancreatic cancer
  44. The altered expression of cytoskeletal and synaptic remodeling proteins during epilepsy
  45. Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
  46. Prostatitis as initial manifestation of Chlamydia psittaci pneumonia diagnosed by metagenome next-generation sequencing: A case report
  47. NUDT21 relieves sevoflurane-induced neurological damage in rats by down-regulating LIMK2
  48. Association of interleukin-10 rs1800896, rs1800872, and interleukin-6 rs1800795 polymorphisms with squamous cell carcinoma risk: A meta-analysis
  49. Exosomal HBV-DNA for diagnosis and treatment monitoring of chronic hepatitis B
  50. Shear stress leads to the dysfunction of endothelial cells through the Cav-1-mediated KLF2/eNOS/ERK signaling pathway under physiological conditions
  51. Interaction between the PI3K/AKT pathway and mitochondrial autophagy in macrophages and the leukocyte count in rats with LPS-induced pulmonary infection
  52. Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
  53. Cloning, subcellular localization and expression of phosphate transporter gene HvPT6 of hulless barley
  54. Coptisine mitigates diabetic nephropathy via repressing the NRLP3 inflammasome
  55. Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis
  56. Whole-exome sequencing applications in prenatal diagnosis of fetal bowel dilatation
  57. Gemella morbillorum infective endocarditis: A case report and literature review
  58. An unusual ectopic thymoma clonal evolution analysis: A case report
  59. Severe cumulative skin toxicity during toripalimab combined with vemurafenib following toripalimab alone
  60. Detection of V. vulnificus septic shock with ARDS using mNGS
  61. Novel rare genetic variants of familial and sporadic pulmonary atresia identified by whole-exome sequencing
  62. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology
  63. Novel compound heterozygous mutations in TELO2 in an infant with You-Hoover-Fong syndrome: A case report and literature review
  64. ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis
  65. Diagnosis of primary amoebic meningoencephalitis by metagenomic next-generation sequencing: A case report
  66. Phylogenetic analysis of promoter regions of human Dolichol kinase (DOLK) and orthologous genes using bioinformatics tools
  67. Collagen changes in rabbit conjunctiva after conjunctival crosslinking
  68. Effects of NM23 transfection of human gastric carcinoma cells in mice
  69. Oral nifedipine and phytosterol, intravenous nicardipine, and oral nifedipine only: Three-arm, retrospective, cohort study for management of severe preeclampsia
  70. Case report of hepatic retiform hemangioendothelioma: A rare tumor treated with ultrasound-guided microwave ablation
  71. Curcumin induces apoptosis in human hepatocellular carcinoma cells by decreasing the expression of STAT3/VEGF/HIF-1α signaling
  72. Rare presentation of double-clonal Waldenström macroglobulinemia with pulmonary embolism: A case report
  73. Giant duplication of the transverse colon in an adult: A case report and literature review
  74. Ectopic thyroid tissue in the breast: A case report
  75. SDR16C5 promotes proliferation and migration and inhibits apoptosis in pancreatic cancer
  76. Vaginal metastasis from breast cancer: A case report
  77. Screening of the best time window for MSC transplantation to treat acute myocardial infarction with SDF-1α antibody-loaded targeted ultrasonic microbubbles: An in vivo study in miniswine
  78. Inhibition of TAZ impairs the migration ability of melanoma cells
  79. Molecular complexity analysis of the diagnosis of Gitelman syndrome in China
  80. Effects of maternal calcium and protein intake on the development and bone metabolism of offspring mice
  81. Identification of winter wheat pests and diseases based on improved convolutional neural network
  82. Ultra-multiplex PCR technique to guide treatment of Aspergillus-infected aortic valve prostheses
  83. Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2
  84. Immune checkpoint inhibitors in cancer patients with COVID-19
  85. Utility of methylene blue mixed with autologous blood in preoperative localization of pulmonary nodules and masses
  86. Integrated analysis of the microbiome and transcriptome in stomach adenocarcinoma
  87. Berberine suppressed sarcopenia insulin resistance through SIRT1-mediated mitophagy
  88. DUSP2 inhibits the progression of lupus nephritis in mice by regulating the STAT3 pathway
  89. Lung abscess by Fusobacterium nucleatum and Streptococcus spp. co-infection by mNGS: A case series
  90. Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
  91. Granulomatous polyangiitis involving the fourth ventricle: Report of a rare case and a literature review
  92. Studying infant mortality: A demographic analysis based on data mining models
  93. Metaplastic breast carcinoma with osseous differentiation: A report of a rare case and literature review
  94. Protein Z modulates the metastasis of lung adenocarcinoma cells
  95. Inhibition of pyroptosis and apoptosis by capsaicin protects against LPS-induced acute kidney injury through TRPV1/UCP2 axis in vitro
  96. TAK-242, a toll-like receptor 4 antagonist, against brain injury by alleviates autophagy and inflammation in rats
  97. Primary mediastinum Ewing’s sarcoma with pleural effusion: A case report and literature review
  98. Association of ADRB2 gene polymorphisms and intestinal microbiota in Chinese Han adolescents
  99. Tanshinone IIA alleviates chondrocyte apoptosis and extracellular matrix degeneration by inhibiting ferroptosis
  100. Study on the cytokines related to SARS-Cov-2 in testicular cells and the interaction network between cells based on scRNA-seq data
  101. Effect of periostin on bone metabolic and autophagy factors during tooth eruption in mice
  102. HP1 induces ferroptosis of renal tubular epithelial cells through NRF2 pathway in diabetic nephropathy
  103. Intravaginal estrogen management in postmenopausal patients with vaginal squamous intraepithelial lesions along with CO2 laser ablation: A retrospective study
  104. Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients
  105. Effects of physical exercise on biomarkers of oxidative stress in healthy subjects: A meta-analysis of randomized controlled trials
  106. Identification of lysosome-related genes in connection with prognosis and immune cell infiltration for drug candidates in head and neck cancer
  107. Development of an instrument-free and low-cost ELISA dot-blot test to detect antibodies against SARS-CoV-2
  108. Research progress on gas signal molecular therapy for Parkinson’s disease
  109. Adiponectin inhibits TGF-β1-induced skin fibroblast proliferation and phenotype transformation via the p38 MAPK signaling pathway
  110. The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
  111. α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
  112. CXCL12/CXCR4/CXCR7 axis in placenta tissues of patients with placenta previa
  113. Association between thyroid stimulating hormone levels and papillary thyroid cancer risk: A meta-analysis
  114. Significance of sTREM-1 and sST2 combined diagnosis for sepsis detection and prognosis prediction
  115. Diagnostic value of serum neuroactive substances in the acute exacerbation of chronic obstructive pulmonary disease complicated with depression
  116. Research progress of AMP-activated protein kinase and cardiac aging
  117. TRIM29 knockdown prevented the colon cancer progression through decreasing the ubiquitination levels of KRT5
  118. Cross-talk between gut microbiota and liver steatosis: Complications and therapeutic target
  119. Metastasis from small cell lung cancer to ovary: A case report
  120. The early diagnosis and pathogenic mechanisms of sepsis-related acute kidney injury
  121. The effect of NK cell therapy on sepsis secondary to lung cancer: A case report
  122. Erianin alleviates collagen-induced arthritis in mice by inhibiting Th17 cell differentiation
  123. Loss of ACOX1 in clear cell renal cell carcinoma and its correlation with clinical features
  124. Signalling pathways in the osteogenic differentiation of periodontal ligament stem cells
  125. Crosstalk between lactic acid and immune regulation and its value in the diagnosis and treatment of liver failure
  126. Clinicopathological features and differential diagnosis of gastric pleomorphic giant cell carcinoma
  127. Traumatic brain injury and rTMS-ERPs: Case report and literature review
  128. Extracellular fibrin promotes non-small cell lung cancer progression through integrin β1/PTEN/AKT signaling
  129. Knockdown of DLK4 inhibits non-small cell lung cancer tumor growth by downregulating CKS2
  130. The co-expression pattern of VEGFR-2 with indicators related to proliferation, apoptosis, and differentiation of anagen hair follicles
  131. Inflammation-related signaling pathways in tendinopathy
  132. CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review
  133. Clinical analysis of severe Chlamydia psittaci pneumonia: Case series study
  134. Bioinformatics analysis to identify potential biomarkers for the pulmonary artery hypertension associated with the basement membrane
  135. Influence of MTHFR polymorphism, alone or in combination with smoking and alcohol consumption, on cancer susceptibility
  136. Catharanthus roseus (L.) G. Don counteracts the ampicillin resistance in multiple antibiotic-resistant Staphylococcus aureus by downregulation of PBP2a synthesis
  137. Combination of a bronchogenic cyst in the thoracic spinal canal with chronic myelocytic leukemia
  138. Bacterial lipoprotein plays an important role in the macrophage autophagy and apoptosis induced by Salmonella typhimurium and Staphylococcus aureus
  139. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data
  140. Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
  141. Ferroptosis: A potential target of macrophages in plaque vulnerability
  142. Predicting pediatric Crohn's disease based on six mRNA-constructed risk signature using comprehensive bioinformatic approaches
  143. Applications of genetic code expansion and photosensitive UAAs in studying membrane proteins
  144. HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
  145. IL-17 in osteoarthritis: A narrative review
  146. Circadian cycle and neuroinflammation
  147. Probiotic management and inflammatory factors as a novel treatment in cirrhosis: A systematic review and meta-analysis
  148. Hemorrhagic meningioma with pulmonary metastasis: Case report and literature review
  149. SPOP regulates the expression profiles and alternative splicing events in human hepatocytes
  150. Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway
  151. PTX3 promotes IVIG resistance-induced endothelial injury in Kawasaki disease by regulating the NF-κB pathway
  152. Pancreatic ectopic thyroid tissue: A case report and analysis of literature
  153. The prognostic impact of body mass index on female breast cancer patients in underdeveloped regions of northern China differs by menopause status and tumor molecular subtype
  154. Report on a case of liver-originating malignant melanoma of unknown primary
  155. Case report: Herbal treatment of neutropenic enterocolitis after chemotherapy for breast cancer
  156. The fibroblast growth factor–Klotho axis at molecular level
  157. Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
  158. A case report of diagnosis and dynamic monitoring of Listeria monocytogenes meningitis with NGS
  159. Effect of autologous platelet-rich plasma on new bone formation and viability of a Marburg bone graft
  160. Small breast epithelial mucin as a useful prognostic marker for breast cancer patients
  161. Continuous non-adherent culture promotes transdifferentiation of human adipose-derived stem cells into retinal lineage
  162. Nrf3 alleviates oxidative stress and promotes the survival of colon cancer cells by activating AKT/BCL-2 signal pathway
  163. Favorable response to surufatinib in a patient with necrolytic migratory erythema: A case report
  164. Case report of atypical undernutrition of hypoproteinemia type
  165. Down-regulation of COL1A1 inhibits tumor-associated fibroblast activation and mediates matrix remodeling in the tumor microenvironment of breast cancer
  166. Sarcoma protein kinase inhibition alleviates liver fibrosis by promoting hepatic stellate cells ferroptosis
  167. Research progress of serum eosinophil in chronic obstructive pulmonary disease and asthma
  168. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases
  169. Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
  170. Precisional detection of lymph node metastasis using tFCM in colorectal cancer
  171. Advances in diagnosis and treatment of perimenopausal syndrome
  172. A study of forensic genetics: ITO index distribution and kinship judgment between two individuals
  173. Acute lupus pneumonitis resembling miliary tuberculosis: A case-based review
  174. Plasma levels of CD36 and glutathione as biomarkers for ruptured intracranial aneurysm
  175. Fractalkine modulates pulmonary angiogenesis and tube formation by modulating CX3CR1 and growth factors in PVECs
  176. Novel risk prediction models for deep vein thrombosis after thoracotomy and thoracoscopic lung cancer resections, involving coagulation and immune function
  177. Exploring the diagnostic markers of essential tremor: A study based on machine learning algorithms
  178. Evaluation of effects of small-incision approach treatment on proximal tibia fracture by deep learning algorithm-based magnetic resonance imaging
  179. An online diagnosis method for cancer lesions based on intelligent imaging analysis
  180. Medical imaging in rheumatoid arthritis: A review on deep learning approach
  181. Predictive analytics in smart healthcare for child mortality prediction using a machine learning approach
  182. Utility of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in predicting acute-on-chronic liver failure survival
  183. A biomedical decision support system for meta-analysis of bilateral upper-limb training in stroke patients with hemiplegia
  184. TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
  185. Stochastic gradient descent optimisation for convolutional neural network for medical image segmentation
  186. Comparison of the prognostic value of four different critical illness scores in patients with sepsis-induced coagulopathy
  187. Application and teaching of computer molecular simulation embedded technology and artificial intelligence in drug research and development
  188. Hepatobiliary surgery based on intelligent image segmentation technology
  189. Value of brain injury-related indicators based on neural network in the diagnosis of neonatal hypoxic-ischemic encephalopathy
  190. Analysis of early diagnosis methods for asymmetric dementia in brain MR images based on genetic medical technology
  191. Early diagnosis for the onset of peri-implantitis based on artificial neural network
  192. Clinical significance of the detection of serum IgG4 and IgG4/IgG ratio in patients with thyroid-associated ophthalmopathy
  193. Forecast of pain degree of lumbar disc herniation based on back propagation neural network
  194. SPA-UNet: A liver tumor segmentation network based on fused multi-scale features
  195. Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image
  196. Rehabilitation effect of intelligent rehabilitation training system on hemiplegic limb spasms after stroke
  197. A novel approach for minimising anti-aliasing effects in EEG data acquisition
  198. ErbB4 promotes M2 activation of macrophages in idiopathic pulmonary fibrosis
  199. Clinical role of CYP1B1 gene polymorphism in prediction of postoperative chemotherapy efficacy in NSCLC based on individualized health model
  200. Lung nodule segmentation via semi-residual multi-resolution neural networks
  201. Evaluation of brain nerve function in ICU patients with Delirium by deep learning algorithm-based resting state MRI
  202. A data mining technique for detecting malignant mesothelioma cancer using multiple regression analysis
  203. Markov model combined with MR diffusion tensor imaging for predicting the onset of Alzheimer’s disease
  204. Effectiveness of the treatment of depression associated with cancer and neuroimaging changes in depression-related brain regions in patients treated with the mediator-deuterium acupuncture method
  205. Molecular mechanism of colorectal cancer and screening of molecular markers based on bioinformatics analysis
  206. Monitoring and evaluation of anesthesia depth status data based on neuroscience
  207. Exploring the conformational dynamics and thermodynamics of EGFR S768I and G719X + S768I mutations in non-small cell lung cancer: An in silico approaches
  208. Optimised feature selection-driven convolutional neural network using gray level co-occurrence matrix for detection of cervical cancer
  209. Incidence of different pressure patterns of spinal cerebellar ataxia and analysis of imaging and genetic diagnosis
  210. Pathogenic bacteria and treatment resistance in older cardiovascular disease patients with lung infection and risk prediction model
  211. Adoption value of support vector machine algorithm-based computed tomography imaging in the diagnosis of secondary pulmonary fungal infections in patients with malignant hematological disorders
  212. From slides to insights: Harnessing deep learning for prognostic survival prediction in human colorectal cancer histology
  213. Ecology and Environmental Science
  214. Monitoring of hourly carbon dioxide concentration under different land use types in arid ecosystem
  215. Comparing the differences of prokaryotic microbial community between pit walls and bottom from Chinese liquor revealed by 16S rRNA gene sequencing
  216. Effects of cadmium stress on fruits germination and growth of two herbage species
  217. Bamboo charcoal affects soil properties and bacterial community in tea plantations
  218. Optimization of biogas potential using kinetic models, response surface methodology, and instrumental evidence for biodegradation of tannery fleshings during anaerobic digestion
  219. Understory vegetation diversity patterns of Platycladus orientalis and Pinus elliottii communities in Central and Southern China
  220. Studies on macrofungi diversity and discovery of new species of Abortiporus from Baotianman World Biosphere Reserve
  221. Food Science
  222. Effect of berrycactus fruit (Myrtillocactus geometrizans) on glutamate, glutamine, and GABA levels in the frontal cortex of rats fed with a high-fat diet
  223. Guesstimate of thymoquinone diversity in Nigella sativa L. genotypes and elite varieties collected from Indian states using HPTLC technique
  224. Analysis of bacterial community structure of Fuzhuan tea with different processing techniques
  225. Untargeted metabolomics reveals sour jujube kernel benefiting the nutritional value and flavor of Morchella esculenta
  226. Mycobiota in Slovak wine grapes: A case study from the small Carpathians wine region
  227. Elemental analysis of Fadogia ancylantha leaves used as a nutraceutical in Mashonaland West Province, Zimbabwe
  228. Microbiological transglutaminase: Biotechnological application in the food industry
  229. Influence of solvent-free extraction of fish oil from catfish (Clarias magur) heads using a Taguchi orthogonal array design: A qualitative and quantitative approach
  230. Chromatographic analysis of the chemical composition and anticancer activities of Curcuma longa extract cultivated in Palestine
  231. The potential for the use of leghemoglobin and plant ferritin as sources of iron
  232. Investigating the association between dietary patterns and glycemic control among children and adolescents with T1DM
  233. Bioengineering and Biotechnology
  234. Biocompatibility and osteointegration capability of β-TCP manufactured by stereolithography 3D printing: In vitro study
  235. Clinical characteristics and the prognosis of diabetic foot in Tibet: A single center, retrospective study
  236. Agriculture
  237. Biofertilizer and NPSB fertilizer application effects on nodulation and productivity of common bean (Phaseolus vulgaris L.) at Sodo Zuria, Southern Ethiopia
  238. On correlation between canopy vegetation and growth indexes of maize varieties with different nitrogen efficiencies
  239. Exopolysaccharides from Pseudomonas tolaasii inhibit the growth of Pleurotus ostreatus mycelia
  240. A transcriptomic evaluation of the mechanism of programmed cell death of the replaceable bud in Chinese chestnut
  241. Melatonin enhances salt tolerance in sorghum by modulating photosynthetic performance, osmoregulation, antioxidant defense, and ion homeostasis
  242. Effects of plant density on alfalfa (Medicago sativa L.) seed yield in western Heilongjiang areas
  243. Identification of rice leaf diseases and deficiency disorders using a novel DeepBatch technique
  244. Artificial intelligence and internet of things oriented sustainable precision farming: Towards modern agriculture
  245. Animal Sciences
  246. Effect of ketogenic diet on exercise tolerance and transcriptome of gastrocnemius in mice
  247. Combined analysis of mRNA–miRNA from testis tissue in Tibetan sheep with different FecB genotypes
  248. Isolation, identification, and drug resistance of a partially isolated bacterium from the gill of Siniperca chuatsi
  249. Tracking behavioral changes of confined sows from the first mating to the third parity
  250. The sequencing of the key genes and end products in the TLR4 signaling pathway from the kidney of Rana dybowskii exposed to Aeromonas hydrophila
  251. Development of a new candidate vaccine against piglet diarrhea caused by Escherichia coli
  252. Plant Sciences
  253. Crown and diameter structure of pure Pinus massoniana Lamb. forest in Hunan province, China
  254. Genetic evaluation and germplasm identification analysis on ITS2, trnL-F, and psbA-trnH of alfalfa varieties germplasm resources
  255. Tissue culture and rapid propagation technology for Gentiana rhodantha
  256. Effects of cadmium on the synthesis of active ingredients in Salvia miltiorrhiza
  257. Cloning and expression analysis of VrNAC13 gene in mung bean
  258. Chlorate-induced molecular floral transition revealed by transcriptomes
  259. Effects of warming and drought on growth and development of soybean in Hailun region
  260. Effects of different light conditions on transient expression and biomass in Nicotiana benthamiana leaves
  261. Comparative analysis of the rhizosphere microbiome and medicinally active ingredients of Atractylodes lancea from different geographical origins
  262. Distinguish Dianthus species or varieties based on chloroplast genomes
  263. Comparative transcriptomes reveal molecular mechanisms of apple blossoms of different tolerance genotypes to chilling injury
  264. Study on fresh processing key technology and quality influence of Cut Ophiopogonis Radix based on multi-index evaluation
  265. An advanced approach for fig leaf disease detection and classification: Leveraging image processing and enhanced support vector machine methodology
  266. Erratum
  267. Erratum to “Protein Z modulates the metastasis of lung adenocarcinoma cells”
  268. Erratum to “BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells”
  269. Retraction
  270. Retraction to “Protocatechuic acid attenuates cerebral aneurysm formation and progression by inhibiting TNF-alpha/Nrf-2/NF-kB-mediated inflammatory mechanisms in experimental rats”
Downloaded on 27.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2022-0700/html
Scroll to top button